Analyst Expectations For Sage Therapeutics's Future
Analyst Expectations For Sage Therapeutics's Future
分析師對sage therapeutics未來的預期
In the last three months, 20 analysts have published ratings on Sage Therapeutics (NASDAQ:SAGE), offering a diverse range of perspectives from bullish to bearish.
在過去的三個月裏，20位分析師對Sage Therapeutics（納斯達克：SAGE）進行了評級，提供了從看好到看淡的多樣化觀點。
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
下表提供了他們最近的評級快照，展示了情緒在過去30天中的演變情況，並將其與之前的月份進行比較。
Insights from analysts' 12-month price targets are revealed, presenting an average target of $19.35, a high estimate of $28.00, and a low estimate of $8.00. This current average has decreased by 23.46% from the previous average price target of $25.28.
分析師12個月目標價展示了一些見解,平均目標價爲$19.35,最高估價爲$28.00,最低估價爲$8.00,這個當前的平均目標價已降低23.46%,相對於先前的平均目標價$25.28。
Breaking Down Analyst Ratings: A Detailed Examination
分析師評級分析：詳細分析
The perception of Sage Therapeutics by financial experts...
通過最近的分析師...
登入免費觀看全文
登入/註冊